Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$8.59 - $20.77 $60,989 - $147,467
7,100 Added 5.43%
137,780 $1.74 Million
Q1 2022

May 16, 2022

SELL
$15.52 - $35.65 $6,208 - $14,260
-400 Reduced 0.31%
130,680 $2.47 Million
Q4 2021

Feb 14, 2022

BUY
$28.89 - $35.33 $379,239 - $463,776
13,127 Added 11.13%
131,080 $4.6 Million
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $948,769 - $1.14 Million
26,606 Added 29.13%
117,953 $4.32 Million
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $460,277 - $762,662
19,421 Added 27.0%
91,347 $3.59 Million
Q1 2021

May 17, 2021

SELL
$27.01 - $36.8 $244,089 - $332,561
-9,037 Reduced 11.16%
71,926 $2.03 Million
Q4 2020

Feb 16, 2021

SELL
$27.51 - $34.36 $126,463 - $157,952
-4,597 Reduced 5.37%
80,963 $2.59 Million
Q3 2020

Nov 16, 2020

SELL
$25.8 - $34.61 $2.1 Million - $2.82 Million
-81,430 Reduced 48.76%
85,560 $2.76 Million
Q2 2020

Aug 14, 2020

SELL
$17.65 - $28.05 $191,855 - $304,903
-10,870 Reduced 6.11%
166,990 $4.61 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $135,494 - $263,229
8,920 Added 5.28%
177,860 $3.17 Million
Q4 2019

Feb 14, 2020

BUY
$17.17 - $25.95 $1.09 Million - $1.65 Million
63,483 Added 60.2%
168,940 $4.24 Million
Q3 2019

Nov 14, 2019

BUY
$17.84 - $22.69 $285,636 - $363,289
16,011 Added 17.9%
105,457 $1.88 Million
Q2 2019

Aug 15, 2019

BUY
$22.0 - $31.78 $1.97 Million - $2.84 Million
89,446 New
89,446 $1.97 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.